NO974995L - Estere av karbapenemer - Google Patents
Estere av karbapenemerInfo
- Publication number
- NO974995L NO974995L NO974995A NO974995A NO974995L NO 974995 L NO974995 L NO 974995L NO 974995 A NO974995 A NO 974995A NO 974995 A NO974995 A NO 974995A NO 974995 L NO974995 L NO 974995L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- group
- alkyl
- optionally substituted
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Det er beskrevet en forbindelse av generell formel (I) hvori R er (a); hvor Ra er hydrogen, eventuelt substituert (Ci^)alkyl eller eventuelt substituert aryl, R« er hydrogen, eventuelt substituert (Ci.«)alk7l eller eventuelt substituert aryl; eller Ra og Rb danner sammen en eventuelt substituert 5 eller 6 leddet heterocyklisk ring med eller uten ytteriigere heteroatomer; R' er (Ci^)alkyl som er usubstituert eller substituert med fluor, en hydroksygruppe som eventuelt er beskyttet med en lett Qembar hydroksybeskyttende gruppe, eller med en aminogruppe som eventuelt er beskTttet med en lett Qembar aminobeskyttende gruppe; R^ er hydrogen eller metyl; og R' er valgt fra gruppen bestående av (a) en gruppe av formel (i) hvor Ri er hydrogen eller (Ci.6)alkyl, R2 er hydrogen, (Ci-6)alk7l eller eventuelt substituert med halogen, (Ci.6)alkenyl, (Ci. 6)alkoksykarbonyl, aryl eller heteroaryl, Rj er hydrogen, (Ci.6)alk7l eller (Ci.«)alkoksy- karbonyl og Rt er en farmasøytisk akseptabel esterdannende gruppe, og (b) en gnjppe av fonnelen CH(R")0.C0.R', hvor R' er hydrogen, (C,.«)alkyl, (C3.7)cykloaIkyl, metyl eller fenyl; og R*" er (Ci.<)alkyl(C3.7)cykloalkyloksy eller (C|.«)alkoksy(Ci.«)alk7l. Forbindelsene er nyttige for behandling av bakterielle infeksjoner.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9508959.5A GB9508959D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
GBGB9508964.5A GB9508964D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
GBGB9508960.3A GB9508960D0 (en) | 1995-05-03 | 1995-05-03 | Novel compounds |
PCT/EP1996/001882 WO1996034869A1 (en) | 1995-05-03 | 1996-05-02 | Esters of carbapenems |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974995D0 NO974995D0 (no) | 1997-10-30 |
NO974995L true NO974995L (no) | 1997-10-30 |
Family
ID=27267697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974995A NO974995L (no) | 1995-05-03 | 1997-10-30 | Estere av karbapenemer |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0823911A1 (no) |
JP (1) | JPH11504912A (no) |
KR (1) | KR19990008354A (no) |
CN (1) | CN1184480A (no) |
AU (1) | AU5814196A (no) |
BR (1) | BR9608318A (no) |
CA (1) | CA2217885A1 (no) |
CZ (1) | CZ347697A3 (no) |
HU (1) | HUP9801061A3 (no) |
MX (1) | MX9708422A (no) |
NO (1) | NO974995L (no) |
PL (1) | PL323148A1 (no) |
TR (1) | TR199701289T2 (no) |
WO (1) | WO1996034869A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100771019B1 (ko) * | 2002-03-20 | 2007-10-29 | 주식회사 만도 | 브레이크 액압제어장치 |
GB0400329D0 (en) * | 2004-01-08 | 2004-02-11 | Glaxo Group Ltd | Novel processes |
GB0400405D0 (en) * | 2004-01-09 | 2004-02-11 | Glaxo Group Ltd | Novel processes |
JP2007039383A (ja) * | 2005-08-03 | 2007-02-15 | Dainippon Sumitomo Pharma Co Ltd | アリールカルバペネム化合物の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1593524A (en) * | 1976-11-19 | 1981-07-15 | Merck & Co Inc | 1-carba-2-penem-3-carboxylic acids |
DK637888A (da) * | 1987-11-24 | 1989-05-25 | Hoffmann La Roche | Carboxylsyreestere |
GB8809534D0 (en) * | 1988-04-22 | 1988-05-25 | Beecham Group Plc | Novel compounds |
PL314173A1 (en) * | 1993-10-29 | 1996-08-19 | Smithkline Beecham Plc | Derivatives of 2-(pyrazol-3-yl)carbapheneme |
-
1996
- 1996-05-02 MX MX9708422A patent/MX9708422A/es unknown
- 1996-05-02 AU AU58141/96A patent/AU5814196A/en not_active Abandoned
- 1996-05-02 JP JP8533022A patent/JPH11504912A/ja active Pending
- 1996-05-02 WO PCT/EP1996/001882 patent/WO1996034869A1/en not_active Application Discontinuation
- 1996-05-02 EP EP96919680A patent/EP0823911A1/en not_active Withdrawn
- 1996-05-02 CA CA002217885A patent/CA2217885A1/en not_active Abandoned
- 1996-05-02 PL PL96323148A patent/PL323148A1/xx unknown
- 1996-05-02 CZ CZ973476A patent/CZ347697A3/cs unknown
- 1996-05-02 BR BR9608318A patent/BR9608318A/pt unknown
- 1996-05-02 TR TR97/01289T patent/TR199701289T2/xx unknown
- 1996-05-02 KR KR1019970707880A patent/KR19990008354A/ko not_active Application Discontinuation
- 1996-05-02 CN CN96194015A patent/CN1184480A/zh active Pending
- 1996-05-02 HU HU9801061A patent/HUP9801061A3/hu unknown
-
1997
- 1997-10-30 NO NO974995A patent/NO974995L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU5814196A (en) | 1996-11-21 |
HUP9801061A3 (en) | 1999-01-28 |
HUP9801061A2 (hu) | 1998-08-28 |
WO1996034869A1 (en) | 1996-11-07 |
EP0823911A1 (en) | 1998-02-18 |
CN1184480A (zh) | 1998-06-10 |
KR19990008354A (ko) | 1999-01-25 |
NO974995D0 (no) | 1997-10-30 |
TR199701289T2 (xx) | 1998-08-21 |
PL323148A1 (en) | 1998-03-16 |
CA2217885A1 (en) | 1996-11-07 |
MX9708422A (es) | 1998-02-28 |
BR9608318A (pt) | 1999-01-26 |
JPH11504912A (ja) | 1999-05-11 |
CZ347697A3 (cs) | 1998-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0870765T3 (da) | Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen | |
TR200400541T4 (tr) | Terapide faydalı tropan türevleri. | |
HRP20020175B1 (en) | N-heterocyclikc derivatives as nos inhibitors | |
NO20065012L (no) | Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse | |
NO982913L (no) | Kinolin- og kinazolinforbindelser nyttige i terapi | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
NO883487L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
NO20015446L (no) | Kinolin-derivater som inhibitorer for MEK-enzymer | |
HUP0001396A2 (hu) | 3-Amino-3 aril-propán-1-ol-származékok, előállításuk és felhasználásuk | |
EP1468692A3 (en) | Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma | |
NO974995L (no) | Estere av karbapenemer | |
DK0785789T3 (da) | Diazepinindoler som phosphodiesterase IV-inhibitorer | |
CA2301967A1 (en) | Azetidinone derivatives for the treatment of hcmv infections | |
MXPA03011032A (es) | Activadores de derivados de oxazol/tiazol del receptor hppar-alfa. | |
DE69201184T2 (de) | 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten. | |
PT1021404E (pt) | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv | |
BG100551A (en) | 2-(pyrazol-3-yl)carbapenem derivatives | |
DE69131774D1 (de) | Antibakterielle penem-ester derivate | |
ES2174077T3 (es) | Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas. | |
EA200500028A1 (ru) | Новые соединения 3-(4-оксо-4h-хромен-2-ил)-(1h)-хинолин-4-она, способ их получения и фармацевтические композиции, которые их содержат | |
NO955071D0 (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
DK0532725T3 (da) | Isoxazolderivater som lysfilterpræparater | |
NO974759L (no) | Cefalosporinpyridiniumderivater | |
NO940321L (no) | Forbindelser med angiotensin II - antagonistisk aktivitet |